Table 1.
Patient, tumor, and treatment characteristics.
| Demographics | GBM Patients (n = 24) |
|---|---|
| Males/Females | 18/6 |
| Median Age at Dx (Range) | 63.5 (41–80) |
| Median KPS (Range) | 80 (50–90) |
| Avg Tumor Size in cm2 (Range) | 21.2 (1.9–41.2) |
| Median OS (Months) | 12.3 |
| Extent of Surgery (% of pts) | |
| GTR | 29.2 |
| STR | 70.8 |
| IDH1 Mutation Status | |
| Wildtype | 22 |
| Mutant | 1 |
| Indeterminate | 1 |
| MGMT Promotor Methylation Status | |
| Unmethylated | 18 |
| Methylated | 6 |
| Indeterminate | 2 |
| Completion of concurrent TMZ (% of pts) | 95.8 |
| Range of RT Dose (Gy) | 60–75 |